Trifenagrel is a platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively.
References:
[1]. Abrahams SL, et al. Trifenagrel: a chemically novel platelet aggregation inhibitor. J Pharmacol Exp Ther. 1989 May;249(2):359-65.
















